The JSE tracked firmer global markets on Monday after another Covid-19 vaccine developer reported encouraging results from its trials, while Shoprite lost the most on the day.

American biotechnology group Moderna said on Monday that its preliminary phase 3 trial data showed its  Covid-19 vaccine was more than 94% effective — a result CEO Stephane Bancel called a “game changer”...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now